SCHEMBL25890396

SCHEMBL25890396

CC(C)N1CC(F)(F)C(F)(C(=O)N(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23324922 0.86
SCHEMBL25953110 0.83 HRH3 (0.30)
SCHEMBL18505952 0.73 SMN1; SMN2 (0.31)
SCHEMBL12205479 0.71 SMN1; SMN2 (0.34)
SCHEMBL23323492 0.70 USP30 (0.31)
SCHEMBL23324541 0.69
SCHEMBL19504943 0.69
SCHEMBL25905688 0.69 CYP2D6 (0.33)
SCHEMBL25953112 0.68
SCHEMBL25953199 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234929-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed